{"id":10195,"date":"2019-07-19T10:12:08","date_gmt":"2019-07-19T08:12:08","guid":{"rendered":"https:\/\/udic.es\/?p=10195"},"modified":"2024-02-14T19:44:15","modified_gmt":"2024-02-14T18:44:15","slug":"paralisi-supranuclear-progressiva-psp-una-terapia-innovadora","status":"publish","type":"post","link":"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/","title":{"rendered":"Par\u00e0lisi supranuclear progressiva (PSP): Una Ter\u00e0pia Innovadora"},"content":{"rendered":"

Hem estat seleccionats per avaluar una ter\u00e0pia innovadora en aquesta terrible malaltia. Iniciarem un assaig cl\u00ednic de fase Ib per avaluar la seguretat d’un antic\u00f2s monoclonal antiTau. Si \u00e9s positiu, participarem en el desenvolupament de l’assaig de fase II per comprovar tamb\u00e9 l’efic\u00e0cia i seguretat de diferents dosis d’aquest f\u00e0rmac.<\/p>\n","protected":false},"excerpt":{"rendered":"

Hem estat seleccionats per avaluar una ter\u00e0pia innovadora en aquesta terrible malaltia. Iniciarem un assaig cl\u00ednic de fase Ib per avaluar la seguretat d’un antic\u00f2s monoclonal antiTau. Si \u00e9s positiu, participarem en el desenvolupament de l’assaig de fase II per comprovar tamb\u00e9 l’efic\u00e0cia i seguretat de diferents dosis d’aquest f\u00e0rmac.<\/p>\n","protected":false},"author":4,"featured_media":9250,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[106],"tags":[],"class_list":["post-10195","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-alzeimer-ca"],"yoast_head":"\nPar\u00e0lisi supranuclear progressiva (PSP): Una Ter\u00e0pia Innovadora - UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica<\/title>\n<meta name=\"description\" content=\"Hem estat seleccionats per avaluar una ter\u00e0pia innovadora en aquesta terrible malaltia. Iniciarem un assaig cl\u00ednic de fase Ib per avaluar la seguretat\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Par\u00e0lisi supranuclear progressiva (PSP): Una Ter\u00e0pia Innovadora - UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\" \/>\n<meta property=\"og:description\" content=\"Hem estat seleccionats per avaluar una ter\u00e0pia innovadora en aquesta terrible malaltia. Iniciarem un assaig cl\u00ednic de fase Ib per avaluar la seguretat\" \/>\n<meta property=\"og:url\" content=\"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/\" \/>\n<meta property=\"og:site_name\" content=\"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci%c3%b3-Cl%c3%adnica-447149502490430\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-07-19T08:12:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-14T18:44:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png\" \/>\n\t<meta property=\"og:image:width\" content=\"815\" \/>\n\t<meta property=\"og:image:height\" content=\"246\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"SUSANA ANDRADE\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"SUSANA ANDRADE\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/\"},\"author\":{\"name\":\"SUSANA ANDRADE\",\"@id\":\"https:\/\/udic.es\/#\/schema\/person\/7b598050df55fbeadbf6cdc699c31c03\"},\"headline\":\"Par\u00e0lisi supranuclear progressiva (PSP): Una Ter\u00e0pia Innovadora\",\"datePublished\":\"2019-07-19T08:12:08+00:00\",\"dateModified\":\"2024-02-14T18:44:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/\"},\"wordCount\":64,\"publisher\":{\"@id\":\"https:\/\/udic.es\/#organization\"},\"image\":{\"@id\":\"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png\",\"articleSection\":[\"Alzeimer\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/\",\"url\":\"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/\",\"name\":\"Par\u00e0lisi supranuclear progressiva (PSP): Una Ter\u00e0pia Innovadora - UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\",\"isPartOf\":{\"@id\":\"https:\/\/udic.es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png\",\"datePublished\":\"2019-07-19T08:12:08+00:00\",\"dateModified\":\"2024-02-14T18:44:15+00:00\",\"description\":\"Hem estat seleccionats per avaluar una ter\u00e0pia innovadora en aquesta terrible malaltia. Iniciarem un assaig cl\u00ednic de fase Ib per avaluar la seguretat\",\"breadcrumb\":{\"@id\":\"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/#primaryimage\",\"url\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png\",\"contentUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png\",\"width\":815,\"height\":246,\"caption\":\"logo\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/udic.es\/ca\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Par\u00e0lisi supranuclear progressiva (PSP): Una Ter\u00e0pia Innovadora\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/udic.es\/#website\",\"url\":\"https:\/\/udic.es\/\",\"name\":\"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\",\"description\":\"Unitat D'Investigaci\u00f3 Cl\u00ednica\",\"publisher\":{\"@id\":\"https:\/\/udic.es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/udic.es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/udic.es\/#organization\",\"name\":\"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\",\"url\":\"https:\/\/udic.es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/udic.es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png\",\"contentUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png\",\"width\":408,\"height\":123,\"caption\":\"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\"},\"image\":{\"@id\":\"https:\/\/udic.es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci\u00f3-Cl\u00ednica-447149502490430\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/udic.es\/#\/schema\/person\/7b598050df55fbeadbf6cdc699c31c03\",\"name\":\"SUSANA ANDRADE\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/udic.es\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ae155cf03dc49fd596e9750d3cfd63ee?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ae155cf03dc49fd596e9750d3cfd63ee?s=96&d=mm&r=g\",\"caption\":\"SUSANA ANDRADE\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Par\u00e0lisi supranuclear progressiva (PSP): Una Ter\u00e0pia Innovadora - UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","description":"Hem estat seleccionats per avaluar una ter\u00e0pia innovadora en aquesta terrible malaltia. Iniciarem un assaig cl\u00ednic de fase Ib per avaluar la seguretat","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/","og_locale":"ca_ES","og_type":"article","og_title":"Par\u00e0lisi supranuclear progressiva (PSP): Una Ter\u00e0pia Innovadora - UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","og_description":"Hem estat seleccionats per avaluar una ter\u00e0pia innovadora en aquesta terrible malaltia. Iniciarem un assaig cl\u00ednic de fase Ib per avaluar la seguretat","og_url":"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/","og_site_name":"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","article_publisher":"https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci%c3%b3-Cl%c3%adnica-447149502490430\/","article_published_time":"2019-07-19T08:12:08+00:00","article_modified_time":"2024-02-14T18:44:15+00:00","og_image":[{"width":815,"height":246,"url":"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png","type":"image\/png"}],"author":"SUSANA ANDRADE","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"SUSANA ANDRADE","Temps estimat de lectura":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/#article","isPartOf":{"@id":"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/"},"author":{"name":"SUSANA ANDRADE","@id":"https:\/\/udic.es\/#\/schema\/person\/7b598050df55fbeadbf6cdc699c31c03"},"headline":"Par\u00e0lisi supranuclear progressiva (PSP): Una Ter\u00e0pia Innovadora","datePublished":"2019-07-19T08:12:08+00:00","dateModified":"2024-02-14T18:44:15+00:00","mainEntityOfPage":{"@id":"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/"},"wordCount":64,"publisher":{"@id":"https:\/\/udic.es\/#organization"},"image":{"@id":"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/#primaryimage"},"thumbnailUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png","articleSection":["Alzeimer"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/","url":"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/","name":"Par\u00e0lisi supranuclear progressiva (PSP): Una Ter\u00e0pia Innovadora - UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","isPartOf":{"@id":"https:\/\/udic.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/#primaryimage"},"image":{"@id":"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/#primaryimage"},"thumbnailUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png","datePublished":"2019-07-19T08:12:08+00:00","dateModified":"2024-02-14T18:44:15+00:00","description":"Hem estat seleccionats per avaluar una ter\u00e0pia innovadora en aquesta terrible malaltia. Iniciarem un assaig cl\u00ednic de fase Ib per avaluar la seguretat","breadcrumb":{"@id":"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/#primaryimage","url":"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png","contentUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png","width":815,"height":246,"caption":"logo"},{"@type":"BreadcrumbList","@id":"https:\/\/udic.es\/ca\/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/udic.es\/ca\/"},{"@type":"ListItem","position":2,"name":"Par\u00e0lisi supranuclear progressiva (PSP): Una Ter\u00e0pia Innovadora"}]},{"@type":"WebSite","@id":"https:\/\/udic.es\/#website","url":"https:\/\/udic.es\/","name":"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","description":"Unitat D'Investigaci\u00f3 Cl\u00ednica","publisher":{"@id":"https:\/\/udic.es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/udic.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/udic.es\/#organization","name":"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","url":"https:\/\/udic.es\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/udic.es\/#\/schema\/logo\/image\/","url":"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png","contentUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png","width":408,"height":123,"caption":"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica"},"image":{"@id":"https:\/\/udic.es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci\u00f3-Cl\u00ednica-447149502490430\/"]},{"@type":"Person","@id":"https:\/\/udic.es\/#\/schema\/person\/7b598050df55fbeadbf6cdc699c31c03","name":"SUSANA ANDRADE","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/udic.es\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ae155cf03dc49fd596e9750d3cfd63ee?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ae155cf03dc49fd596e9750d3cfd63ee?s=96&d=mm&r=g","caption":"SUSANA ANDRADE"}}]}},"_links":{"self":[{"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/posts\/10195"}],"collection":[{"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/comments?post=10195"}],"version-history":[{"count":1,"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/posts\/10195\/revisions"}],"predecessor-version":[{"id":10196,"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/posts\/10195\/revisions\/10196"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/media\/9250"}],"wp:attachment":[{"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/media?parent=10195"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/categories?post=10195"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/udic.es\/ca\/wp-json\/wp\/v2\/tags?post=10195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}